Literature DB >> 16558628

Asthma medications: basic pharmacology and use in the athlete.

J E Houglum1.   

Abstract

OBJECTIVE: Asthma is a chronic disease that affects athletes at all levels of sport. Several categories of drugs, including relatively new agents, are available to treat the asthmatic patient. By understanding the appropriate uses and effects of these drugs, the athletic trainer can assist the asthmatic athlete in improving therapeutic outcomes from the asthma therapy. The appropriate use of these medications includes not only the use of the appropriate drug(s), but also appropriate technique for administration, compliance with the prescribed dosing intervals, and sufficient care to avoid side effects. DATA SOURCES: I searched MEDLINE and CINAHL from 1982 to 1999 and International Pharmaceutical Abstracts from 1990 to 1999. Terms searched were "asthma," "athlete,""athletic," "exercise-induced," "exercise," "performance," "therapy," and "treatment." DATA SYNTHESIS: Bronchodilators include beta2 agonists, anticholinergics, and methylxanthines. Of these, the beta2 agonists used by inhalation are the drugs of choice to treat an acute asthma attack or to prevent an anticipated attack (such as before exercise). Anti-inflammatory agents include corticosteroids mast cell-stabilizing agents, and antileukotrienes. Corticosteroids by inhalation are the drugs of choice for long-term treatment to curb the inflammatory process in the lung. Each of these drug categories has a unique mechanism of action. The athletic trainer who understands the appropriate use of these medications can help the athlete to obtain optimal results from drug therapy. Encouraging the athlete to comply with appropriate therapy, monitoring the effectiveness of the therapy, and recognizing the stimuli that initiate asthmatic attacks can improve the patient's therapeutic outcomes. CONCLUSIONS/RECOMMENDATIONS: The athletic trainer has an opportunity to play a key role in ensuring that the asthmatic athlete achieves the desired outcomes from treatment. The athletic trainer can help to minimize the effect of asthma on athletic performance by ensuring that the athlete uses inhaler devices properly, is compliant with the prescribed drug therapy, monitors pulmonary function appropriately, uses medications properly before exercise, and is aware of the factors that initiate asthma symptoms.

Entities:  

Year:  2000        PMID: 16558628      PMCID: PMC1323415     

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  36 in total

1.  Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma.

Authors:  S Schuh; D W Johnson; D Stephens; S Callahan; P Winders; G J Canny
Journal:  J Pediatr       Date:  1999-07       Impact factor: 4.406

Review 2.  New millennium bronchodilators for asthma: single-isomer beta agonists.

Authors:  D A Handley; A J Anderson; J Koester; M E Snider
Journal:  Curr Opin Pulm Med       Date:  2000-01       Impact factor: 3.155

3.  Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment.

Authors:  R L Green; A G Vayonis
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

4.  Difficult asthma or Churg-Strauss syndrome?

Authors:  D P D'Cruz; N C Barnes; C M Lockwood
Journal:  BMJ       Date:  1999-02-20

5.  Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast.

Authors:  M Kinoshita; T Shiraishi; T Koga; M Ayabe; T Rikimaru; K Oizumi
Journal:  J Allergy Clin Immunol       Date:  1999-03       Impact factor: 10.793

6.  High-intensity physical training in adults with asthma. A comparison between training on land and in water.

Authors:  M Emtner; M Finne; G Stålenheim
Journal:  Scand J Rehabil Med       Date:  1998-12

7.  Asthma in United States Olympic athletes who participated in the 1996 Summer Games.

Authors:  J M Weiler; T Layton; M Hunt
Journal:  J Allergy Clin Immunol       Date:  1998-11       Impact factor: 10.793

8.  A 3-year follow-up of asthmatic patients participating in a 10-week rehabilitation program with emphasis on physical training.

Authors:  M Emtner; M Finne; G Stålenheim
Journal:  Arch Phys Med Rehabil       Date:  1998-05       Impact factor: 3.966

9.  Comparing the delivery of albuterol metered-dose inhaler via an adapter and spacer device in an in vitro infant ventilator lung model.

Authors:  M L Avent; P Gal; J L Ransom; Y L Brown; C J Hansen
Journal:  Ann Pharmacother       Date:  1999-02       Impact factor: 3.154

10.  Effect of long-term salmeterol treatment on exercise-induced asthma.

Authors:  J A Nelson; L Strauss; M Skowronski; R Ciufo; R Novak; E R McFadden
Journal:  N Engl J Med       Date:  1998-07-16       Impact factor: 91.245

View more
  3 in total

1.  Adherence to drug-dispensation and drug-administration laws and guidelines in collegiate athletic training rooms: a 5-year review.

Authors:  Leamor Kahanov; Jeff Roberts; Emily M Wughalter
Journal:  J Athl Train       Date:  2010 May-Jun       Impact factor: 2.860

2.  National Athletic Trainers' Association position statement: management of asthma in athletes.

Authors:  Michael G Miller; John M Weiler; Robert Baker; James Collins; Gilbert D'Alonzo
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

3.  Seeing the Forest Through the Wheeze: A Case-Study Approach to Diagnosing Paradoxical Vocal-Cord Dysfunction.

Authors:  Michael C Koester; Chris L Amundson
Journal:  J Athl Train       Date:  2002-09       Impact factor: 2.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.